Sponsors (2)
Official title: To establish a grant program to provide schools with opioid overdose reversal drugs, to direct schools receiving Federal funds to report to certain Federal information systems any distribution of an opioid overdose reversal drug, and for other purposes.
Introduced March 19, 2026 by Raul Ruiz · Last progress March 19, 2026
The bill rapidly equips schools with naloxone and improves overdose surveillance and training in high-need areas to save lives in the short term, but relies on one-year funding and creates reporting, compliance, and privacy burdens that may limit long-term sustainability and strain school and public health resources.
Students and school staff nationwide gain on-site access to naloxone kits so overdoses on school grounds are more likely to be reversed quickly.
Schools must report naloxone distributions to national systems, improving overdose surveillance so public health agencies can identify local patterns and target prevention or rapid response near schools.
Schools receive grant funding to develop CPR, overdose response, and prevention programming, improving emergency readiness and student/community education.
Schools and students may lose ongoing access to naloxone and sustainment of training because grants are limited to one-year awards, risking gaps once funding ends.
Schools, especially small, under-resourced, and private institutions, face significant administrative burden and compliance costs (applications, assurances, reporting, new systems) that consume staff time and resources.
Students and staff face privacy risks because distribution events are reported to centralized systems unless data protections are specified, potentially exposing sensitive information.
Based on analysis of 3 sections of legislative text.
Creates 1-year HHS grants for schools to buy opioid overdose reversal drugs and require federally funded schools to report drug distributions to NEMSIS and ODMAP.
Provides one-year competitive HHS grants to eligible schools and related entities to buy FDA-approved opioid overdose reversal drugs and to create and deliver training and prevention resources, prioritizing areas with high overdose rates. Requires federally funded elementary and secondary schools, including charter schools, to report any distributions of overdose reversal drugs to the National Emergency Medical Services Information System (NEMSIS) and the Overdose Detection Mapping Application Program (ODMAP).